Unified Huntington's disease rating scale: Reliability and consistency

! The Unified Huntington’s Disease Rating Scale (UHDRS) was developed as a clinical rating scale to assess four domains of clinical performance and capacity in HD: motor function, cognitive function, behavioral abnormalities, and functional capacity. We assessed the internal consistency and the intercorrelations for the four domains and examined changes in ratings over time. We also performed an interrater reliability study of the motor assessment. We found there was a high degree of internal consistency within each of the domains of the UHDRS and that there were significant intercorrelations between the domains of the UHDRS, with the exception of the total behavioral score. There was an excellent degree of interrater reliability for the motor scores. Our limited longitudinal database indicates that the UHDRS may be useful for tracking changes in the clinical features of HD over time. The UHDRS assesses relevant clinical features of HD and appears to be appropriate for repeated administration during clinical studies.\

[1]  J. Obeso Movement disorders , 1998, Stereotactic and functional neurosurgery.

[2]  Rush-Presbyterian-St. Luke's Medical Center and Others v. Hellenic Republic and Others , 1995, International Law Reports.

[3]  G. Bruyn,et al.  Duration of illness in Huntington's disease is not related to age at onset. , 1993, Journal of neurology, neurosurgery, and psychiatry.

[4]  S. Folstein,et al.  Assessment of adaptive functioning in huntington's disease , 1993, Movement disorders : official journal of the Movement Disorder Society.

[5]  D. Sax,et al.  Factors associated with slow progression in Huntington's disease. , 1991, Archives of neurology.

[6]  R. Hichwa,et al.  PET scan investigations of Huntington's disease: Cerebral metabolic correlates of neurological features and functional decline , 1986, Annals of neurology.

[7]  R J Leigh,et al.  The measurement of abnormal movement: methods developed for Huntington's disease. , 1983, Neurobehavioral toxicology and teratology.

[8]  C D Marsden,et al.  Assessment of extrapyramidal disorders. , 1981, British journal of clinical pharmacology.